Research Articles | Page 7 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro Jun 2020 Experimental Hematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro May 2020 Experimental Hematology Myelodysplastic Syndromes (MDS)
Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: A multicenter real-world retrospective study Jun 2023 European Journal of Haematology Aplastic Anemia
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes Jan 2021 American Journal of Hematology Myelodysplastic Syndromes (MDS)
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study Oct 2023 Leukemia Aplastic Anemia
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study Dec 2023 Leukemia Aplastic Anemia
Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms Jul 2019 Surgical Pathology Clinic Myelodysplastic Syndromes (MDS)
Detectable mutations precede late myeloid neoplasia in aplastic anemia Feb 2021 Haematologica Aplastic Anemia
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates Jan 2019 Semin Hematol Paroxysmal Nocturnal Hemoglobinuria (PNH)